| 產(chǎn)品描述： | Brivudine is a thymidine analogue with antiviral activity, indicated for the early treatment of acute herpes zoster. |
| 靶點： |
CMV;HSV |
| 體內(nèi)研究： |
At a dose of 125 mg once daily, brivudine has proved to be superior to aciclovir with respect to reducing the period of new blister production, and has shortened the duration of post-herpetic neuralgia |
| 參考文獻： |
1. Rabasseda X, et al. Brivudine: a herpes virostatic with rapid antiviral activity and once-daily dosing. Drugs Today (Barc). 2003 May;39(5):359-71. 2. Keam SJ, et al. Brivudin (bromovinyl deoxyuridine). Drugs. 2004;64(18):2091-7; discussion 2098-9. |
| 溶解性： |
DMSO : 200 mg/mL (600.35 mM; Need ultrasonic) |
| 保存條件： |
2-8℃ |
| 配置溶液濃度參考： |
|
1mg |
5mg |
10mg |
| 1 mM |
3.002 ml |
15.009 ml |
30.017 ml |
| 5 mM |
0.6 ml |
3.002 ml |
6.003 ml |
| 10 mM |
0.3 ml |
1.501 ml |
3.002 ml |
| 50 mM |
0.06 ml |
0.3 ml |
0.6 ml |
|
| 注意： |
部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。 |
上海工商
危險品化學品經(jīng)營許可證（不帶存儲）
營業(yè)執(zhí)照(三證合一)
北京